排名
最低EV/EBITDA — Healthcare
企业价值与息税折旧摊销前利润之比。较低可能意味着低估。
共 79 家公司有EV/EBITDA数据。
按EV/EBITDA排名(79)
| # | 代码 | 名称 | 市值 | EV/EBITDA |
|---|---|---|---|---|
| 1 | RIGL | $564M | 0.9 | |
| 2 | AGEN | $146M | 1.3 | |
| 3 | CYRX | $791M | 4.7 | |
| 4 | BTMD | $61M | 4.8 | |
| 5 | CF | $17.3B | 5.0 | |
| 6 | COLL | $1.1B | 5.6 | |
| 7 | MOS | $7.6B | 5.7 | |
| 8 | GPRE | $1.1B | 6.5 | |
| 9 | TGTX | $5.8B | 7.4 | |
| 10 | ANIP | $1.8B | 7.5 | |
| 11 | CBT | $4.5B | 7.5 | |
| 12 | LXU | $902M | 7.9 | |
| 13 | AMPH | $831M | 7.9 | |
| 14 | PAHC | $1.2B | 8.1 | |
| 15 | ADMA | $1.8B | 8.6 | |
| 16 | VTRS | $18.9B | 9.0 | |
| 17 | OLN | $2.9B | 9.6 | |
| 18 | FUL | $3.5B | 9.7 | |
| 19 | AVNT | $3.2B | 9.8 | |
| 20 | ZTS | $32.6B | 9.9 | |
| 21 | BMY | $116.8B | 10.1 | |
| 22 | SEE | $6.2B | 10.2 | |
| 23 | SCL | $1.2B | 10.2 | |
| 24 | CLX | $10.9B | 10.6 | |
| 25 | PPG | $25.2B | 10.9 | |
| 26 | TEVA | $41.1B | 11.0 | |
| 27 | BHC | $2.0B | 11.0 | |
| 28 | REGN | $64.5B | 11.0 | |
| 29 | ALTO | $422M | 11.1 | |
| 30 | EMN | $8.7B | 11.2 | |
| 31 | NEU | $7.1B | 11.2 | |
| 32 | IPAR | $3.0B | 11.7 | |
| 33 | BIIB | $28.9B | 11.8 | |
| 34 | IFF | $19.4B | 11.9 | |
| 35 | KVUE | $33.2B | 12.2 | |
| 36 | PFE | $149.2B | 12.3 | |
| 37 | VHI | $407M | 13.1 | |
| 38 | AMGN | $181.8B | 13.6 | |
| 39 | RPM | $13.5B | 13.8 | |
| 40 | LNTH | $6.5B | 13.8 | |
| 41 | PG | $334.3B | 14.5 | |
| 42 | SMG | $3.4B | 14.6 | |
| 43 | GILD | $166.9B | 15.0 | |
| 44 | FTK | $722M | 15.4 | |
| 45 | JNJ | $542.4B | 17.1 | |
| 46 | ABT | $149.1B | 17.4 | |
| 47 | SRPT | $1.9B | 18.1 | |
| 48 | HALO | $7.9B | 18.2 | |
| 49 | ICCC | $93M | 18.4 | |
| 50 | LXFR | $460M | 18.4 | |
| 51 | LIN | $230.1B | 18.6 | |
| 52 | CHD | $22.7B | 18.8 | |
| 53 | SXT | $4.8B | 19.8 | |
| 54 | APD | $62.0B | 20.0 | |
| 55 | MRK | $293.2B | 20.7 | |
| 56 | CL | $72.1B | 20.9 | |
| 57 | BMRN | $11.1B | 21.5 | |
| 58 | LGND | $4.6B | 21.6 | |
| 59 | ECL | $72.0B | 22.3 | |
| 60 | SOLS | $13.4B | 23.0 | |
| 61 | COTY | $1.9B | 24.4 | |
| 62 | WDFC | $2.7B | 24.8 | |
| 63 | HXL | $6.8B | 25.0 | |
| 64 | LYB | $21.5B | 26.9 | |
| 65 | EL | $32.2B | 27.3 | |
| 66 | ALB | $20.8B | 27.4 | |
| 67 | IDXX | $44.5B | 28.7 | |
| 68 | DD | $19.6B | 28.8 | |
| 69 | EPC | $807M | 30.2 | |
| 70 | TECH | $8.1B | 31.4 | |
| 71 | CE | $5.8B | 32.7 | |
| 72 | DOW | $24.3B | 34.9 | |
| 73 | RGEN | $7.0B | 40.7 | |
| 74 | HUN | $2.7B | 42.9 | |
| 75 | ABBV | $384.7B | 45.6 | |
| 76 | FOLD | $4.5B | 87.9 | |
| 77 | MNKD | $1.2B | 105.5 | |
| 78 | AMTX | $179M | 218.6 | |
| 79 | JAZZ | $14.8B | 7261.0 |
如何把排名页用到估值流程里
先看公司页
先确认商业模式、利润率、资本结构和当前估值倍数,避免只看单一排名就下结论。
再验证 WACC
倍数看起来便宜,不代表折现率合理。先验证资本成本,再决定 DCF 假设。
最后进入 DCF
用同一家公司对应的 DCF 页面验证合理价值区间,避免排名、倍数和现金流假设互相脱节。
其他板块 EV/EBITDA 排名
数据每日更新 · 来源: SEC EDGAR, Polygon.io